Literature DB >> 15000419

Behavioral and caregiver reaction of dementia as measured by the neuropsychiatric inventory in Nigerian community residents.

Olusegun Baiyewu1, Valerie Smith-Gamble, Akinsola Akinbiyi, Kathleen A Lane, Kathleen S Hall, Adesola Ogunniyi, Oyewusi Gureje, Hugh C Hendrie.   

Abstract

BACKGROUND: The Neuropsychiatric Inventory (NPI) has been used to assess behavioral symptoms of dementia in the United States, Taiwan, Japan, and Italy.
METHOD: This report evaluates the use of the NPI to assess behavioral symptoms of dementia in a population of Yoruba, Nigerians aged 65 years and older who are subjects in the Indianapolis-Ibadan Dementia Project. In this study, the NPI, Blessed Dementia Scale, and Mini-Mental State Examination (MMSE) were used to assess Nigerian subjects with dementia. For this study the NPI was translated, back translated, and harmonized into Yoruba.
RESULTS: The harmonized version of the NPI showed good interrater and test-retest reliability. The Cronbach alpha on 40 subjects was .80 for total severity score, .73 for frequency, and .73 for distress, indicating good internal consistency. The MMSE correlated with the NPI total score and severity scores of delusion, hallucination, and agitation, whereas the Blessed correlated with the NPI total score and severity scores of depression, anxiety, and nighttime behavior.
CONCLUSIONS: The NPI was found to be a reliable tool to assess behavioral symptoms and caregiver distress of dementia in the Yoruba. Behavioral disturbances were as common in the Yoruba patients with dementia as in studies in other countries that have used the NPI, but the pattern of behavioral disturbances and caregiver response varied among the countries.

Entities:  

Mesh:

Year:  2003        PMID: 15000419     DOI: 10.1017/s1041610203009645

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  7 in total

1.  Behavioral symptoms in community-dwelling elderly Nigerians with dementia, mild cognitive impairment, and normal cognition.

Authors:  Olusegun Baiyewu; Fred W Unverzagt; Adesola Ogunniyi; Valerie Smith-Gamble; Oye Gureje; Kathleen A Lane; Sujuan Gao; Kathleen S Hall; Hugh C Hendrie
Journal:  Int J Geriatr Psychiatry       Date:  2012-03-02       Impact factor: 3.485

Review 2.  Experiences and practices of caregiving for older persons living with dementia in African countries: A qualitative scoping review.

Authors:  Isaac A Adedeji; Adesola Ogunniyi; David C Henderson; Nadia A Sam-Agudu
Journal:  Dementia (London)       Date:  2022-01-03

3.  Factors associated with emotional distress among caregivers of patients with schizophrenia in Katsina, Nigeria.

Authors:  Abdulkareem Jika Yusuf; Folorunsho Tajudeen Nuhu
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-11-12       Impact factor: 4.328

Review 4.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

5.  Validation Study of the Korean Version of the Brief Clinical Form of the Neuropsychiatric Inventory.

Authors:  Hee-Jin Kim; Kyoung Hue Choi; Seung H Kim; Jeffrey L Cummings; Dong-Won Yang
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-06-03

6.  Association of caregiver demographic variables with neuropsychiatric symptoms in Alzheimer's disease patients for distress on the Neuropsychiatric Inventory (NPI).

Authors:  Cláudia Godinho; Analuiza Camozzato; Renata Kochhann; Márcia Lorena Fagundes Chaves
Journal:  Dement Neuropsychol       Date:  2008 Jul-Sep

Review 7.  Psychometric Properties of the Neuropsychiatric Inventory: A Review.

Authors:  Toni Saari; Anne Koivisto; Taina Hintsa; Tuomo Hänninen; Ilona Hallikainen
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.